Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT)

Historical Holders from Q3 2016 to Q4 2025

Symbol
FLGT on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
30,210,911
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
17,228,107
Holdings value
$389,318,961
% of all portfolios
0%
Number of holders
162
Number of buys
73
Number of sells
75
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BARCLAYS PLC 7.6% +43% $42,396,117 +$12,335,507 2,338,451 +41% Barclays PLC 31 Mar 2025
BlackRock, Inc. 5.9% $32,993,391 1,819,823 BlackRock, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 5.6% +18% $33,633,203 +$4,961,034 1,691,811 +17% Millennium Management LLC 22 Jul 2025
As of 30 Sep 2025 Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,228,107 shares of 30,210,911 outstanding shares and own 57% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) own 47% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
BlackRock, Inc. 9.8% $67,244,288 2,975,411 +38%
MILLENNIUM MANAGEMENT LLC 4.9% $33,195,874 1,468,844 +1.8%
VANGUARD GROUP INC 3.9% $26,651,141 1,179,254 +1.1%
ACADIAN ASSET MANAGEMENT LLC 3.8% $25,754,000 1,140,163 +2%
DIMENSIONAL FUND ADVISORS LP 3.8% $25,607,425 1,133,103 -0.12%
D. E. Shaw & Co., Inc. 1.9% $12,831,602 567,770 +19%
DEUTSCHE BANK AG\ 1.7% $11,401,361 504,485 +52%
STATE STREET CORP 1.7% $11,345,110 501,996 -2.3%
GEODE CAPITAL MANAGEMENT, LLC 1.7% $11,339,902 501,671 -2.3%
AMERIPRISE FINANCIAL INC 1.6% $11,185,938 494,953 -0.69%
CITADEL ADVISORS LLC 1.2% $8,395,357 371,476 -38%
Point72 Asset Management, L.P. 1.2% $8,390,505 371,261 -32%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% $8,119,751 359,281 +20%
Connor, Clark & Lunn Investment Management Ltd. 1.1% $7,492,488 331,526 +8.6%
JPMORGAN CHASE & CO 0.99% $6,757,717 299,014 +767%
Nuveen, LLC 0.96% $6,573,278 290,853 -5.8%
MORGAN STANLEY 0.92% $6,250,214 276,558 +23%
Diametric Capital, LP 0.8% $5,460,657 241,622 +43%
NORTHERN TRUST CORP 0.66% $4,538,668 200,826 +0.2%
GOLDMAN SACHS GROUP INC 0.61% $4,158,355 183,998 +58%
BARCLAYS PLC 0.59% $4,042,394 178,867 -9.5%
Trexquant Investment LP 0.57% $3,895,607 172,372 +42%
TUDOR INVESTMENT CORP ET AL 0.57% $3,875,787 171,495 -7.3%
Peapod Lane Capital LLC 0.54% $3,719,789 164,579 +1.1%
TWO SIGMA INVESTMENTS, LP 0.52% $3,561,941 157,608 +68%

Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 4,596 $120,737 +$1,077 $26.27 1
2025 Q3 17,228,107 $389,318,961 +$21,532,521 $22.60 162
2025 Q2 16,260,263 $323,227,753 +$1,152,439 $19.88 165
2025 Q1 16,317,307 $275,768,406 -$14,217,098 $16.90 173
2024 Q4 17,016,195 $314,285,279 +$12,985,883 $18.47 185
2024 Q3 16,092,056 $349,642,907 +$18,556,959 $21.73 181
2024 Q2 15,271,785 $299,655,107 +$9,367,412 $19.62 170
2024 Q1 14,727,786 $319,564,135 +$6,539,138 $21.70 177
2023 Q4 14,302,809 $413,495,913 +$4,547,542 $28.91 193
2023 Q3 14,229,204 $380,479,266 +$6,537,668 $26.74 196
2023 Q2 13,900,018 $514,629,091 +$13,570,378 $37.03 210
2023 Q1 13,537,003 $422,618,519 +$14,324,645 $31.22 213
2022 Q4 13,130,080 $391,069,830 -$9,588,373 $29.78 218
2022 Q3 13,298,290 $506,859,271 -$7,820,533 $38.12 217
2022 Q2 12,997,411 $708,963,224 +$53,955,153 $54.53 247
2022 Q1 12,047,292 $751,600,750 +$40,161,746 $62.41 263
2021 Q4 11,205,792 $1,127,293,672 -$26,292,784 $100.59 284
2021 Q3 11,367,430 $1,022,253,660 +$64,809,061 $89.95 258
2021 Q2 10,632,791 $980,578,944 +$54,311,867 $92.23 246
2021 Q1 10,008,047 $966,031,706 +$64,885,192 $96.62 243
2020 Q4 9,615,937 $501,565,082 +$82,198,208 $52.10 184
2020 Q3 8,084,326 $323,850,761 +$79,786,110 $40.04 122
2020 Q2 6,322,946 $101,163,272 +$14,541,369 $16.00 81
2020 Q1 6,111,180 $65,545,855 +$3,544,598 $10.76 72
2019 Q4 5,668,534 $73,105,675 +$35,387,759 $12.90 70
2019 Q3 2,927,084 $30,408,049 +$16,888,791 $10.39 33
2019 Q2 1,301,144 $8,691,007 +$411,415 $6.68 12
2019 Q1 1,242,460 $7,393,006 +$220,569 $5.95 15
2018 Q4 1,210,059 $3,835,003 -$982,557 $3.17 13
2018 Q3 1,458,250 $5,731,004 +$22,470 $3.93 15
2018 Q2 1,452,436 $6,013,004 +$11,608 $4.14 15
2018 Q1 1,449,767 $5,789,004 +$112,502 $3.99 18
2017 Q4 1,415,208 $6,199,004 -$6,549,628 $4.38 16
2017 Q3 2,390,312 $11,378,005 -$4,107,706 $4.79 19
2017 Q2 2,976,441 $19,019,006 -$5,819,346 $6.39 20
2017 Q1 3,492,074 $38,134,153 +$4,840,117 $10.92 35
2016 Q4 3,066,506 $35,477,491 +$5,733,496 $11.57 36
2016 Q3 2,647,726 $24,413,000 +$24,413,000 $9.22 16